مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

865
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EVALUATION OF EFFECT OF CAPTOPRIL ON LEFT CARDIAC FUNCTION IN PATIENTS WITH MAJOR β-THALASSEMIA

Pages

  492-498

Abstract

 Objective: Major b -thalassemia is a fatal and severe haemolytic anaemia that causes failure to thrive, body organs dysfunction and iron over load. Cardiac complications are the major cause of death among patients with b -thalassemiamajor. The purpose of this study was to evaluate the cardiac function in patient with b thalassemia major after treatment with the CAPTOPRILSubjects and methods: Sixty patients from 110 major b-thalassemiccases, aged between 10 to 21 years, we are selected and underwent this pilot clinical trial. Patients were divided into two groups: before and after receiving CAPTOPRIL or received placebo. Two-D and Doppler echocardiography were taken. The data were statistically analyzed with SPSS soft-ware using students’ t-test and correlation coefficient methods.Results: After treatment with CAPTOPRIL in comparison with the before treatment, the mean Ejection Fraction increased from 54.35%±7.7% to 58.74%±8.7% (p<0.05), Shortening Fraction increased from 28.12±5 to 31.03±6 (p<0.05), Left Ventricular E/A ratio decreased from 1.88±0.37 to 1.69±0.41 (p<0.05), PEPIET in left side decreased from 0.38±0.05 to 0.32±0.08 (p<0.05), deceleration time of mitral inflow increased from 122±24 to 142±32msec (p<0.05), and LVESD decreased from 3.4±0.5 to 3.1±0.4 (p<0.05). In the control group, after treatment with placebo compared before treatment, mean of EF decreased from 58.73%±5.3% to 54.63%±8% (p<0.05), Shortening Fraction decreased from 31.63±4 to 28.6±5 (P<0.05), deceleration time of mitral inflow increased from 140±19 to 192±18msec (P<0.05).Conclusion: These results showed that CAPTOPRIL is effective in improving the cardiac function in major thalassemic patients. Furthermore, it is also useful in subsets of patients with heart failure, especially in those with restrictive filling pattern.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    NOURI, NOUR MOHAMMAD, & ESHGHI, P.. (2008). EVALUATION OF EFFECT OF CAPTOPRIL ON LEFT CARDIAC FUNCTION IN PATIENTS WITH MAJOR β-THALASSEMIA. JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL, 6(4 (55)), 492-498. SID. https://sid.ir/paper/12846/en

    Vancouver: Copy

    NOURI NOUR MOHAMMAD, ESHGHI P.. EVALUATION OF EFFECT OF CAPTOPRIL ON LEFT CARDIAC FUNCTION IN PATIENTS WITH MAJOR β-THALASSEMIA. JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL[Internet]. 2008;6(4 (55)):492-498. Available from: https://sid.ir/paper/12846/en

    IEEE: Copy

    NOUR MOHAMMAD NOURI, and P. ESHGHI, “EVALUATION OF EFFECT OF CAPTOPRIL ON LEFT CARDIAC FUNCTION IN PATIENTS WITH MAJOR β-THALASSEMIA,” JUNDISHAPUR SCIENTIFIC MEDICAL JOURNAL, vol. 6, no. 4 (55), pp. 492–498, 2008, [Online]. Available: https://sid.ir/paper/12846/en

    Related Journal Papers

    Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top